Furthermore, that CLA-elicited insulin resistance and hepatic steatosis were absent in BMSO-treated mice [4], could be secondary responses to lipoatrophy, as a lack of adiponectin, rather than WAT inflammation, was the underlying cause of lipoatrophy-accompanied metabolic disturbance [35,39]. The gene discussed is ADIPOQ; the disease is Hepatic steatosis.